Related Experiment Video
Updated: Jul 11, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Toxic UDPGA Accumulation Is a Metabolic Vulnerability of Cancer Cells
Abstract:
UXS1-mediated clearance of the sugar nucleotide UDPGA is a specific vulnerability of cancer cells.
Insights
Cancer cells have a specific weakness related to the sugar nucleotide UDP-glucose acid (UDPGA). This vulnerability is caused by the enzyme UXS1, which clears UDPGA, offering a potential target for cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cancer cells exhibit altered metabolic pathways compared to normal cells.
- Specific metabolic enzymes can represent unique vulnerabilities in malignant cells.
- UDP-glucose acid (UDPGA) is a crucial sugar nucleotide involved in various biosynthetic processes.
Purpose of the Study:
- To investigate the role of UXS1 in cancer cell metabolism.
- To identify specific metabolic vulnerabilities in cancer cells.
- To explore UXS1 as a potential therapeutic target in oncology.
Main Methods:
- Analysis of gene expression and protein levels of UXS1 in cancer cell lines.
- Metabolic flux analysis to quantify UDPGA levels and turnover.
- CRISPR-Cas9 gene editing to modulate UXS1 activity.
- Cell viability assays under different metabolic conditions.
Main Results:
- UXS1 expression and activity are elevated in various cancer cells.
- UXS1-mediated clearance of UDPGA is significantly higher in cancer cells.
- Inhibition or knockout of UXS1 leads to UDPGA accumulation and reduced cancer cell viability.
- Cancer cells exhibit a specific dependency on UXS1 for managing UDPGA levels.
Conclusions:
- UXS1-mediated UDPGA clearance represents a specific vulnerability of cancer cells.
- Targeting UXS1 could be a promising therapeutic strategy for cancer treatment.
- Understanding cancer-specific metabolic dependencies is key for developing novel anti-cancer drugs.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

